December

• December 26, 2005
• NDA for Immunosuppressant FK506 Modified Release Formulation Submitted in the US

• December 21, 2005
• Study design and patient background of a large-scale clinical study, INNOVATION, of the angiotensin II receptor blocker MICARDIS was published in medical journal (pdf 2.7MB)

• December 16, 2005
• Astellas Transfers Its Group Member Company FMS Co., Ltd. to Canon System Solutions Inc. of the Canon Sales Group (pdf 11KB)

• December 16, 2005
• CO-Promotion Agreement between Astellas and sanofi-aventis Group Japan for Hypnotic Myslee (zolpidem tartrate) (pdf 11KB)

• December 9, 2005
• Purchase of the Company's Own Shares in the Market (pdf 8KB)

• December 1, 2005
• XenoPort and Astellas Enter a License Agreement on XP13512 in Japan and Five Asian Countries (pdf 36KB)

November

• November 29, 2005
• Astellas Sues Toyo Pharmar and Aska Pharmaceutical for Infringement of Patent on Harnal Capsule

• November 8, 2005
• Theravance and Astellas to Collaborate on Telavancin, Investigational Antibiotic for Serious Infections (pdf 25KB)

• November 7, 2005
• Notice Regarding Acquisition of the Company's Own Shares (pdf 9KB)

• November 7, 2005
• Astellas Revises Its Dividends Forecasts for Current Fiscal Year (pdf 12KB)

• November 2, 2005
• Collaborative Search for Microorganisms in Vietnam (pdf 15KB)

October

• October 28, 2005
• Astellas Announces Dissolution of Astellas Systems (pdf 44KB)

• October 28, 2005
• Astellas and Fujitsu Sign Agreemet for Information-System Outsourcing (pdf 12KB)

• October 26, 2005
• Revision of the Interim and Full Year Business Forecasts for FY2005 (pdf 24KB)

• October 21, 2005
• Invention Encouragement Prize of the FY2005 Kanto Local Commendation for Invention Was Awarded to Astellas' fast-disintegrating Tablet Technology WOWTAB-DRY

• October 12, 2005
• Astellas to Support the Relief Effort Following Earthquake Struck in Northern Pakistan

• October 12, 2005
• Luvox^® Receives Approval for Social Anxiety Disorder as an Additional Indication

• October 4, 2005
• Astellas and MerLion Pharmaceuticals announce new drug discovery agreement (pdf 33KB)

September

• September 15, 2005
• Astellas Filed Lawsuit against Taiyo Yakuhin Co., Ltd. for Infringement of Patent on the Oral Cephalosporin Antibiotic Cefzon Capsule

• September 5, 2005
• Astellas to Support the Relief Effort Following Hurricane Katrina Hit in the US

• September 1, 2005
• Purchase of the Company's Own Shares in the Market (pdf 8KB)

• September 1, 2005
• Transfer of Almatol tablets and HelmitinS suppositories to Choseido (pdf 11KB)

August

• August 24, 2005
• Finalized Plan for Separation of the API Production at Takahagi Site (pdf 34KB)

• August 24, 2005
• Allotment of Stock Acquisition Rights as Stock Option Scheme for Stock-Linked Compensation Plan (pdf 12KB)

• August 11, 2005
• Astellas Will Implement Early Retirement Programs at Its Domestic Subsidiaries (pdf 9KB)

• August 2, 2005
• Notice Regarding Acquisition of the Company's Own Shares (pdf 16KB)

July

• July 19, 2005
• International Symposium on "Telmisartan(MICARDIS)" (pdf 156KB)

• July 6, 2005
• Astellas has ended the agreement regarding "Aczone^TM" in North America

June

• June 24, 2005
• Separation of the API Production at Takahagi Site

• June 10, 2005
• The Orally Disintegrating Tablet "Harnal^® D Tablet" for the Treatment of Functional Symptoms of Benign Prostatic Hyperplasia to be Available in Japan

May

• May 27, 2005
• Astellas US LLC and Astellas Pharma US, Inc. Filed Lawsuit against Adenoscan Generic for Patent Infringement in the USA

• May 17, 2005
• Issuance of Stock Acquisition Rights as Stock Option Scheme for Stock-Linked Compensation Plan (pdf 15KB)

• May 17, 2005
• Astellas will Dissolve its Subsidiary for Home Care business

• May 16, 2005
• Astellas will Withdraw from its Medical Supplies and Systems Business

• May 16, 2005
• Astellas and Boehringer Filed Lawsuit against FLOMAX^® Generic for Patent Infringement in the USA

• May 13, 2005
• Anti-fungal Agent MYCAMINE^TM Available to Physicians

April

• April 11, 2005
• Prograf ^® Is Approved For Additional Indication of Rheumatoid Arthritis

• April 1, 2005
• Astellas Pharma Start Today As A New Star in the World Pharmaceutical Industry

March

• March 18, 2005
• Astellas Pharma Inc.Appoints Representative Directors and Corporate Officers (pdf 47KB)

• March 17, 2005
• Astellas Pharma Inc.:Organization of Overseas Group Companies and Their Top Management (pdf 22KB)

---

• Message
• Business Philosophy
• VISION 2015
• CSR-Based Management
• Governance & Internal Control
• Business Activities
• Corporate Profile
• Disclosure Policy
• News Release
  • 2010
  • 2009
  • 2008
  • Past news
    • 2007
    • 2006
    • 2005
    • 2004
  • Yamanouchi
  • Fujisawa